NOV 02, 2016 8:51 AM PDT

Mutation Allows Liver Cancer Cells to Escape Limbo

WRITTEN BY: Xuan Pham

Increasingly, doctors are recognizing the impact of genetic differences on disease and treatment outcomes. This realization is impetus behind so many genetic testing initiatives, all with the goal of customizing treatments for individuals. Now, genetic research into liver cancer revealed a specific mutation, and patients with this disease profile may benefit from 2 different types of drugs already available.
 
Liver cancer is the tenth most common cancer, affecting over 39,000 people every year. Of this, it’s estimated that over 27,000 deaths from liver cancer will occur this year alone, making it the fifth most common cause of cancer death in men.
 
"Liver cancer is a deadly disease," said Luca Tordella, a postdoctoral scientist at the Imperial College London, and the study’s first author. But because the disease is modulated by different factors, no single treatment is effective for everyone. In particular, Tordella said, “It's important to better classify patients into groups, according to their genes. One advance of personalised medicine is to understand which drug will work best on you, and which on me."
 
Tordella’s team searched through the DNA of 100 people with liver cancer. They zeroed in on genes involved with cell senescence – a state of cellular limbo that prevents cancer from forming.
 
In their quest, the team stumbled on a mutation in the Arid1b gene, which allows cancer cells to bypass the senescence checkpoint. In essence, the mutation lets cells leave limbo and go on dividing uncontrollably – the hallmark of cancer cell progression.
 


This mechanism of liver cancer progression is part of a bigger pathway known as the SWI/SNF complex. "Around 20% of patients with liver cancer have mutations on the genes encoding for components of the SWI/SNF complex. What we suggest is if we treat these people with drugs that target the degradation of nucleotides, they will respond," said Jesus Gil, the study’s senior author. "We plan to continue to research this in the lab to develop treatments to target liver cancer."
 
Importantly, this complex has been successfully targeted by other cancer drugs, namely gemcitabine. This chemotherapy drug has been used to treat non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer.
 

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 25, 2020
Cancer
Using RNA to Diagnose HPV Associated Cancer
NOV 25, 2020
Using RNA to Diagnose HPV Associated Cancer
Diagnostic tools are critical to modern medicine. They might be less exciting than a good therapy or drug, but doctors a ...
DEC 14, 2020
Cancer
Fibronectin Could Act as a Biomarker for Early Prognosis of Live Cancer
DEC 14, 2020
Fibronectin Could Act as a Biomarker for Early Prognosis of Live Cancer
Diagnostics is one of the key pillars of modern medicine. Diagnostics allows patients and doctors to identify a problem ...
JAN 14, 2021
Clinical & Molecular DX
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
JAN 14, 2021
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
  Only 10 percent of icebergs are visible on the surface of the water; the remaining 90 percent remains submerged. ...
JAN 15, 2021
Genetics & Genomics
Rare Quadruple Helix DNA Found in Live Human Cells
JAN 15, 2021
Rare Quadruple Helix DNA Found in Live Human Cells
Many people picture the classic double-stranded helix when picturing a molecule of DNA, but DNA is also capable of formi ...
JAN 20, 2021
Genetics & Genomics
Mutations in One Gene Can Lead to Cancer in Different Ways
JAN 20, 2021
Mutations in One Gene Can Lead to Cancer in Different Ways
Cancer and genetics are linked; for example, when a cell's genome accumulates mutations it can begin to divide uncon ...
Loading Comments...